In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Video Forum: Ellen Kelsay, Business Group on Health
Examining health care through the lens of employers.
Video Forum: Nicholas Hall, Nicholas Hall Group of Companies, Part 2
Self-care to play bigger part in treatment and prevention.
Video Forum: Nicholas Hall, Nicholas Hall Group of Companies, Part 1
Charting the trajectory of self-care.
Latest
Clorox buys GOJO Industries, the makers of Purell
Expands Clorox's position in health and hygiene to include skin hygiene
FMI celebrates the food industry’s legacy with the 2026 Executive Leadership Awards
"This year’s Executive Leadership Award recipients demonstrate how excellence is accumulated over one’s lifetime, and they exemplify what true leadership in the food industry looks like"
RangeMe Top Brands: Food & Beverage
Learn about the RangeMe Top 50 Food & Beverage brands and more at RangeMe.com
Dollar General expands same-day delivery reach as myDG service scales nationwide
Retailer extends digital convenience to rural communities while strengthening omnichannel ecosystem